December 16, 2015 /

Understanding the Potential of Epicatechin (December 2015)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Understanding the Potential of Epicatechin (December 2015)

On December 16, 2015, PPMD Founding President and CEO, Pat Furlong interviewed Dr. George Schreiner, President and CSO of Cardero Therapeutics, Inc. to discuss the potential benefits of epicatechin to people with Duchenne. It was a fascinating conversation about an all-natural therapy that could benefit the entire Duchenne population, regardless of age or gene mutation. 

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo